Wells Fargo Downgrades Solutia (SOA) to Market Perform; Eastman Chemical (EMN) Offer Solid
SOA Hot Sheet
Rating Summary:1 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Wells Fargo downgraded Solutia (NYSE: SOA) from Outperform to Market Perform, price target range raised to $27-$28 from $20-22.
Wells analyst says, "We are downgrading our rating on SOA shares reflecting full valuation post the Eastman Chemical (NYSE: EMN) acquisition news. With the shares now trading above our previous valuation range, at nearly 8x our 2012 EBITDA estimate, and with the likelihood of another competing bid unlikely, in our view, we find further appreciation potential limited."
For an analyst ratings summary and ratings history on Solutia click here. For more ratings news on Solutia click here.
Shares of Solutia closed at $27.52 yesterday, with a 52 week range of $11.27-$27.89.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
Wells analyst says, "We are downgrading our rating on SOA shares reflecting full valuation post the Eastman Chemical (NYSE: EMN) acquisition news. With the shares now trading above our previous valuation range, at nearly 8x our 2012 EBITDA estimate, and with the likelihood of another competing bid unlikely, in our view, we find further appreciation potential limited."
For an analyst ratings summary and ratings history on Solutia click here. For more ratings news on Solutia click here.
Shares of Solutia closed at $27.52 yesterday, with a 52 week range of $11.27-$27.89.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Goldman Sachs Downgrades Raytheon (RTN) to Sell; Risk To Back-End Loaded 2012
- Caris & Co. Downgrades Viacom (VIA) to Above Average
Create E-mail Alert Related Categories
DowngradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
